Elevated vitreous body glial fibrillary acidic protein in retinal diseases.

Anselm Gerhard Maria JünemannRobert RejdakCord HuchzermeyerRyszard MaciejewskiPawel GriebFriedrich E KruseEberhart ZrennerKonrad RejdakAxel Petzold

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2015)

The data suggest that human vitreous body GFAP is a protein biomarker for glial activation in response to retinal pathologies. Vitreous body GFAP levels may be of interest as a surrogate outcome for experimental treatment strategies in translational studies.

Keyphrases

optical coherence tomography
diabetic retinopathy
endothelial cells
neuropathic pain
protein protein
amino acid
optic nerve
binding protein
electronic health record